Browse by People

Collapse authors list.
Wilding, John PH ORCID: 0000-0003-2839-8404, Evans, Marc, Fernando, Kevin, Luis Gorriz, Jose, Cebrian, Ana, Diggle, Jane, Hicks, Debbie, James, June, Newland-Jones, Philip, Ali, Amar et al (show 6 more authors) , Bain, Stephen, Da Porto, Andrea, Patel, Dipesh, Viljoen, Adie, Wheeler, David C and Del Prato, Stefano (2022) The Place and Value of Sodium-Glucose Cotransporter 2 Inhibitors in the Evolving Treatment Paradigm for Type 2 Diabetes Mellitus: A Narrative Review. DIABETES THERAPY, 13 (5). pp. 847-872.

Collapse authors list.
Wilding, John ORCID: 0000-0003-2839-8404, Fernando, Kevin, Milne, Nicola, Evans, Marc, Ali, Amar, Bain, Steve, Hicks, Debbie, James, June, Newland-Jones, Philip, Patel, Dipesh et al (show 1 more authors) and Viljoen, Adie (2018) SGLT2 Inhibitors in Type 2 Diabetes Management: Key Evidence and Implications for Clinical Practice. DIABETES THERAPY, 9 (5). pp. 1757-1773.

Collapse authors list.
Ali, Amar, Bain, Steve, Hicks, Debbie, Jones, Phillip Newland, Patel, Dipesh C, Evans, Marc, Fernando, Kevin, James, June, Milne, Nicola, Viljoen, Adie et al (show 1 more authors) and Wilding, John ORCID: 0000-0003-2839-8404 (2019) SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c-Translating Evidence into Practice. DIABETES THERAPY, 10 (5). pp. 1595-1622.

Collapse authors list.
Wheeler, David C, James, June, Patel, Dipesh, Viljoen, Adie, Ali, Amar, Evans, Marc, Fernando, Kevin, Hicks, Debbie, Milne, Nicola, Newland-Jones, Philip et al (show 1 more authors) and Wilding, John ORCID: 0000-0003-2839-8404 (2020) SGLT2 Inhibitors: Slowing of Chronic Kidney Disease Progression in Type 2 Diabetes. DIABETES THERAPY, 11 (12). pp. 2757-2774.